Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer. (Q38403484)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22583908%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22583908%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

Karina Dalsgaard Sørensen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22583908%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Richard Morgan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22583908%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Hardev Pandha

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22583908%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Thorsten F Orntoft

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22583908%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Stephen Langley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22583908%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Soren Hoyer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22583908%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Michael Borre

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22583908%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

15 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22583908%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22583908%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22583908%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

6 Pt B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22583908%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

E287-92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22583908%20AND%20SRC:MED&resulttype=core&format=json

The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11208.X

Correlation between serum prostate-specific antigen and cancer volume in prostate glands of different sizes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11208.X

Pathological outcomes of candidates for active surveillance of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11208.X

A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11208.X

Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11208.X

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11208.X

Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11208.X

Biological determinants of cancer progression in men with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11208.X

Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11208.X

An analysis of men with clinically localized prostate cancer who deferred definitive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11208.X

PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11208.X

PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11208.X

Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11208.X

Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11208.X

Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11208.X

10.1111/J.1464-410X.2012.11208.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22583908%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference